Balance sheet remains conservative with D/E at 0.69 and total debt stable around $5.3B, while equity grew to $7.5B, though a PPE data anomaly in 2026Q1 warrants investigation.
Universal Health Services, Inc. (UHS) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 3.68B | 3.41B | 2.82B | 2.81B | 2.54B | 2.26B | 3.28B | 1.92B | 1.94B | 1.8B | 1.68B | 1.72B | 1.62B | 1.43B | 1.41B | 1.36B | 1.33B | 796.2M | 789.42M | 774.85M | 728.51M | 608.3M | 808.92M | 645.79M | 593.62M | 548.26M | 476.45M | 403.2M | 319.6M | 230M | 194M |
| Cash & Short-Term Investments | 138.8M | 137.8M | 125.98M | 119.44M | 102.82M | 115.3M | 1.22B | 61.27M | 105.22M | 74.42M | 33.75M | 61.23M | 32.07M | 17.24M | 23.47M | 41.23M | 29.47M | 9.18M | 5.46M | 16.35M | 14.94M | 7.96M | 33.13M | 34.86M | 17.75M | 22.85M | 10.54M | 6.2M | 1.3M | 300K | 300K |
| Cash Only | 138.8M | 137.8M | 125.98M | 119.44M | 102.82M | 115.3M | 1.22B | 61.27M | 105.22M | 74.42M | 33.75M | 61.23M | 32.07M | 17.24M | 23.47M | 41.23M | 29.47M | 9.18M | 5.46M | 16.35M | 14.94M | 7.96M | 33.13M | 34.86M | 17.75M | 22.85M | 10.54M | 6.2M | 1.3M | 300K | 300K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.8B | 2.6B | 2.18B | 2.24B | 2.02B | 1.75B | 1.73B | 1.56B | 1.51B | 1.5B | 1.44B | 1.3B | 1.28B | 1.12B | 1.07B | 969.8M | 837.82M | 602.56M | 625.44M | 627.19M | 595.01M | 499.73M | 552.54M | 503.93M | 474.76M | 418.08M | 376.6M | 307.3M | 256.4M | 180.3M | 145.4M |
| Days Sales Outstanding | 54.07 | 54.7 | 50.22 | 57.2 | 54.96 | 50.43 | 54.6 | 50.07 | 51.16 | 52.63 | 53.8 | 52.57 | 58.05 | 55.97 | 55.96 | 47.2 | 54.92 | 42.28 | 45.45 | 48.18 | 51.82 | 46.35 | 51.21 | 50.48 | 53.17 | 53.72 | 61.3 | 54.92 | 49.93 | 45.62 | 44.59 |
| Inventory | 234.09M | 232.11M | 220.94M | 216.99M | 218.52M | 206.84M | 190.42M | 159.89M | 148.21M | 136.18M | 125.36M | 116.04M | 108.11M | 101.78M | 99M | 96.78M | 94.33M | 84.27M | 76.04M | 72.4M | 64.53M | 52.84M | 60.73M | 61.74M | 58.22M | 0 | 45.52M | 41.2M | 38.8M | 28.2M | 22M |
| Days Inventory Outstanding | 49.88 | 51.07 | 50.79 | 51.67 | 54.1 | 52.9 | 53.96 | 46.64 | 46.29 | 44.98 | 44.37 | 43.48 | 44.06 | 45.24 | 45.19 | 43.85 | 48.03 | 10.59 | 9.82 | 39.66 | 42.99 | 9.11 | 11.35 | 20.13 | 17.52 | - | 20.34 | 31.65 | 32.33 | 17.91 | 17.49 |
| Other Current Assets | 505.32M | 381.57M | 291.61M | 236.66M | 198.28M | 194.78M | 138.03M | 133.93M | 174.47M | 86.5M | 82.71M | 238.61M | 192.22M | 196.35M | 217.83M | 257.1M | 369.49M | 100.19M | 82.48M | 58.91M | 54.03M | 47.77M | 162.53M | 45.26M | 42.89M | 107.33M | 43.79M | 48.5M | 23.1M | 21.2M | 26.3M |
| Total Non-Current Assets | 12.26B | 12.55B | 11.65B | 11.16B | 10.96B | 10.83B | 10.2B | 9.75B | 9.33B | 8.96B | 8.64B | 7.9B | 7.36B | 6.88B | 6.79B | 6.3B | 6.2B | 3.17B | 2.95B | 2.83B | 2.55B | 2.25B | 2.21B | 2.13B | 1.74B | 1.62B | 1.27B | 1.09B | 1.13B | 855.3M | 771.8M |
| Property, Plant & Equipment | 7.51B | 7.38B | 6.99B | 6.56B | 6.37B | 6.24B | 5.71B | 5.34B | 4.85B | 4.57B | 4.33B | 3.84B | 3.68B | 3.44B | 3.38B | 3.29B | 3.25B | 2.32B | 2.1B | 1.93B | 1.69B | 1.43B | 1.45B | 1.3B | 1.17B | 1.03B | 875.63M | 777.1M | 808.8M | 663.1M | 567.6M |
| Fixed Asset Turnover | 2.00x | 2.35x | 2.26x | 2.18x | 2.10x | 2.03x | 2.02x | 2.13x | 2.22x | 2.28x | 2.25x | 2.36x | 2.19x | 2.12x | 2.06x | 2.28x | 1.71x | 2.25x | 2.39x | 2.46x | 2.49x | 2.75x | 2.72x | 2.79x | 2.78x | 2.75x | 2.56x | 2.63x | 2.32x | 2.18x | 2.10x |
| Goodwill | 3.98B | 3.99B | 3.93B | 3.93B | 3.91B | 3.96B | 3.88B | 3.87B | 3.84B | 3.83B | 3.78B | 3.6B | 3.29B | 3.05B | 3.04B | 2.63B | 2.59B | 732.68M | 732.94M | 750.39M | 719.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 75.88M | 76.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 686.21M | 619.06M | 442.5M | 410.32M | 372.63M | 316.78M | 276M | 279.1M | 149.8M | 150.3M |
| Long-Term Investments | 346.23M | 346.23M | 318.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 702.35M | 254.5M | 216.19M | 579.73M | 605.89M | 579.9M | 579.97M | 523.15M | 629.83M | 563.83M | 520.13M | 465.05M | 388.4M | 388.21M | 374.35M | 384.76M | 353.94M | 120.34M | 119.82M | 149.5M | 143.46M | 134.55M | 146.79M | 380.09M | 152M | 216.5M | 73.52M | 41.7M | 40.6M | 42.4M | 53.9M |
| Total Assets | 15.94B | 15.96B | 14.47B | 13.97B | 13.49B | 13.09B | 13.48B | 11.67B | 11.27B | 10.76B | 10.32B | 9.62B | 8.97B | 8.31B | 8.2B | 7.67B | 7.53B | 3.96B | 3.74B | 3.61B | 3.28B | 2.86B | 3.02B | 2.77B | 2.33B | 2.17B | 1.74B | 1.5B | 1.45B | 1.09B | 965.8M |
| Asset Turnover | 1.15x | 1.09x | 1.09x | 1.02x | 0.99x | 0.97x | 0.86x | 0.98x | 0.96x | 0.97x | 0.95x | 0.94x | 0.90x | 0.88x | 0.85x | 0.98x | 0.74x | 1.31x | 1.34x | 1.32x | 1.28x | 1.38x | 1.30x | 1.31x | 1.40x | 1.31x | 1.29x | 1.36x | 1.29x | 1.33x | 1.23x |
| Asset Growth % | 28.93% | 10.28% | 3.6% | 3.51% | 3.06% | -2.84% | 15.5% | 3.58% | 4.68% | 4.3% | 7.3% | 7.14% | 7.97% | 1.35% | 6.99% | 1.82% | 89.89% | 5.93% | 3.71% | 10.12% | 14.63% | -5.43% | 9.02% | 19.05% | 7.4% | 24.46% | 16.31% | 3.45% | 33.43% | 12.37% | 29.1% |
| Total Current Liabilities | 3.3B | 3.24B | 2.21B | 2.01B | 1.91B | 1.98B | 2.48B | 1.56B | 1.45B | 1.85B | 1.32B | 1.1B | 1.18B | 1.06B | 894.06M | 836.93M | 826.3M | 582.82M | 561.13M | 487.71M | 502.45M | 524.17M | 469.66M | 395.75M | 370.41M | 322.72M | 248.84M | 217.2M | 170.1M | 160.5M | 140.1M |
| Accounts Payable | 2.45B | 750.13M | 632M | 613.97M | 636.6M | 658.9M | 570.52M | 446.96M | 445.65M | 441.98M | 439.67M | 366.24M | 336.45M | 276.91M | 247.03M | 228.04M | 252.49M | 194.97M | 192.08M | 175.22M | 190.16M | 421.29M | 190.18M | 178.82M | 170.47M | 144.16M | 113.29M | 105.3M | 165.7M | 153.1M | 57.1M |
| Days Payables Outstanding | 426.74 | 165.04 | 145.28 | 146.2 | 157.6 | 168.52 | 161.66 | 130.37 | 139.19 | 145.98 | 155.6 | 137.23 | 137.1 | 123.1 | 112.76 | 103.34 | 128.55 | 24.51 | 24.79 | 95.98 | 126.68 | 72.67 | 35.53 | 58.32 | 51.31 | 78.77 | 50.63 | 80.9 | 138.05 | 97.22 | 45.39 |
| Short-Term Debt | 771.91M | 821.39M | 40.06M | 126.69M | 81.45M | 48.41M | 332M | 87.55M | 63.45M | 545.62M | 105.89M | 62.72M | 68.32M | 99.31M | 2.59M | 2.48M | 3.45M | 2.57M | 8.71M | 3.12M | 1.94M | 5.19M | 16.97M | 10.87M | 8.25M | 2.44M | 689K | 3.5M | 4.1M | 5.7M | 6.9M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 5.38M | 2.4M | 6K | 376.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 984.56M | 622.63M | 549.47M | 470.86M | 466.35M | 410.17M | 524.63M | 472.53M | 343.22M | 275.29M | 245.12M | 323.43M | 278.21M | 260.5M | 235.91M | 521.03M | 354.24M | 0 | 287.73M | 0 | -243.69M | 21.12M | 0 | 0 | 0 | 134.86M | 108.4M | 300K | 1.7M | 76.1M |
| Current Ratio | 1.12x | 1.05x | 1.27x | 1.40x | 1.33x | 1.14x | 1.32x | 1.23x | 1.34x | 0.97x | 1.28x | 1.56x | 1.37x | 1.35x | 1.57x | 1.63x | 1.61x | 1.37x | 1.41x | 1.59x | 1.45x | 1.16x | 1.72x | 1.63x | 1.60x | 1.70x | 1.91x | 1.86x | 1.88x | 1.43x | 1.38x |
| Quick Ratio | 1.04x | 0.98x | 1.17x | 1.29x | 1.21x | 1.04x | 1.25x | 1.12x | 1.24x | 0.90x | 1.18x | 1.46x | 1.27x | 1.26x | 1.46x | 1.52x | 1.50x | 1.22x | 1.27x | 1.44x | 1.32x | 1.06x | 1.59x | 1.48x | 1.45x | 1.70x | 1.73x | 1.67x | 1.65x | 1.26x | 1.23x |
| Cash Conversion Cycle | -322.79 | -59.27 | -44.27 | -37.33 | -48.54 | -65.19 | -53.11 | -33.66 | -41.74 | -48.38 | -57.43 | -41.19 | -35 | -21.88 | -11.62 | -12.29 | -25.6 | 28.36 | 30.48 | -8.14 | -31.87 | -17.21 | 27.02 | 12.3 | 19.38 | - | 31.01 | 5.67 | -55.8 | -33.7 | 16.69 |
| Total Non-Current Liabilities | 4.98B | 5.31B | 5.5B | 5.75B | 5.61B | 4.91B | 4.59B | 4.52B | 4.35B | 3.86B | 4.39B | 3.96B | 3.76B | 3.73B | 4.31B | 4.26B | 4.47B | 1.39B | 1.41B | 1.6B | 1.2B | 969.56M | 1.15B | 1.13B | 901.02M | 912.06M | 656.17M | 523.6M | 521.6M | 398.2M | 372.7M |
| Long-Term Debt | 4.08B | 4.26B | 4.46B | 4.79B | 4.73B | 4.14B | 3.52B | 3.9B | 3.94B | 3.49B | 4.03B | 3.37B | 3.21B | 3.21B | 3.73B | 3.65B | 3.91B | 956.43M | 990.66M | 1.01B | 821.36M | 637.65M | 852.23M | 868.57M | 680.51M | 718.83M | 548.06M | 419.2M | 418.2M | 272.5M | 275.6M |
| Capital Lease Obligations | 1.11B | 426.1M | 376.24M | 382.56M | 395.52M | 304.62M | 278.3M | 270.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 441.61M | 435.14M | 0 | 0 | 0 | 0 | 5.58M | 25.07M | 49.66M | 54.96M | 88.12M | 315.9M | 282.21M | 239.15M | 183.75M | 209.59M | 173.35M | 60.09M | 12.44M | 40.02M | 35.89M | 42.71M | 50.21M | 41.84M | 14.27M | 28.84M | 36.38M | 30.6M | 23.3M | 500K | 0 |
| Other Non-Current Liabilities | 559.96M | 187.11M | 655.81M | 584.01M | 487.67M | 464.76M | 458.55M | 329.93M | 361.81M | 306.3M | 275.17M | 278.83M | 268.56M | 284.59M | 395.36M | 401.91M | 380.65M | 375.58M | 407.65M | 554.94M | 340.81M | 289.19M | 243.62M | 216.09M | 206.24M | 164.39M | 71.73M | 73.8M | 80.1M | 125.2M | 97.1M |
| Total Liabilities | 8.28B | 8.55B | 7.71B | 7.77B | 7.52B | 6.9B | 7.07B | 6.09B | 5.8B | 5.7B | 5.71B | 5.06B | 4.94B | 4.79B | 5.2B | 5.1B | 5.29B | 1.97B | 1.97B | 2.09B | 1.7B | 1.49B | 1.62B | 1.52B | 1.27B | 1.23B | 905.01M | 740.8M | 691.7M | 558.7M | 512.8M |
| Total Debt | 5.26B | 5.51B | 4.96B | 5.37B | 5.27B | 4.56B | 4.19B | 4.31B | 4B | 4.04B | 4.14B | 3.43B | 3.28B | 3.31B | 3.73B | 3.65B | 3.92B | 959M | 999.37M | 1.01B | 823.3M | 642.85M | 869.2M | 879.44M | 688.77M | 721.27M | 548.75M | 422.7M | 422.3M | 278.2M | 282.5M |
| Net Debt | 5.12B | 5.37B | 4.83B | 5.25B | 5.17B | 4.44B | 2.97B | 4.25B | 3.89B | 3.97B | 4.1B | 3.37B | 3.25B | 3.29B | 3.71B | 3.61B | 3.89B | 949.82M | 993.91M | 995.55M | 808.36M | 634.88M | 836.07M | 844.57M | 671.02M | 698.42M | 538.21M | 416.5M | 421M | 277.9M | 282.2M |
| Debt / Equity | 0.69x | 0.74x | 0.73x | 0.87x | 0.88x | 0.74x | 0.65x | 0.77x | 0.73x | 0.80x | 0.90x | 0.75x | 0.81x | 0.94x | 1.24x | 1.42x | 1.75x | 0.48x | 0.56x | 0.67x | 0.52x | 0.47x | 0.62x | 0.70x | 0.65x | 0.77x | 0.66x | 0.56x | 0.56x | 0.53x | 0.62x |
| Debt / EBITDA | 1.95x | 2.11x | 2.19x | 3.08x | 3.32x | 2.40x | 2.24x | 2.53x | 2.46x | 2.34x | 2.44x | 2.07x | 2.28x | 2.45x | 2.98x | 3.06x | 5.37x | 1.32x | 1.65x | 1.83x | 1.70x | 1.35x | 1.82x | 0.90x | 1.52x | 1.86x | 1.77x | 1.57x | 1.60x | 1.35x | 1.60x |
| Net Debt / EBITDA | 1.90x | 2.06x | 2.13x | 3.01x | 3.26x | 2.34x | 1.59x | 2.49x | 2.39x | 2.29x | 2.42x | 2.03x | 2.26x | 2.43x | 2.96x | 3.03x | 5.33x | 1.31x | 1.64x | 1.80x | 1.67x | 1.33x | 1.75x | 0.86x | 1.48x | 1.80x | 1.73x | 1.54x | 1.59x | 1.35x | 1.60x |
| Interest Coverage | 13.99x | 13.51x | 8.96x | 5.53x | 7.80x | 16.15x | 12.45x | 7.55x | 7.63x | 8.88x | 10.84x | 12.00x | 8.94x | 7.39x | 5.65x | 4.29x | 6.40x | 11.37x | 7.73x | 3.43x | 8.35x | 9.54x | 4.84x | 21.88x | 6.28x | 2.51x | 6.60x | 3.68x | 4.40x | 6.47x | 3.55x |
| Total Equity | 7.66B | 7.41B | 6.76B | 6.2B | 5.97B | 6.2B | 6.41B | 5.58B | 5.47B | 5.06B | 4.61B | 4.55B | 4.03B | 3.52B | 3B | 2.57B | 2.24B | 1.99B | 1.77B | 1.52B | 1.58B | 1.36B | 1.41B | 1.25B | 1.06B | 933.81M | 837.36M | 757.2M | 756.4M | 526.6M | 453M |
| Equity Growth % | 36.27% | 9.56% | 9.04% | 3.88% | -3.68% | -3.25% | 14.75% | 2.07% | 8.14% | 9.79% | 1.21% | 12.93% | 14.56% | 17.27% | 16.95% | 14.75% | 12.36% | 12.37% | 16.7% | -3.76% | 15.5% | -3% | 12.53% | 18.23% | 13.27% | 11.52% | 10.59% | 0.11% | 43.64% | 16.25% | 52.17% |
| Book Value per Share | 127.71 | 114.94 | 99.61 | 88.44 | 80.86 | 74.06 | 74.85 | 62.70 | 58.35 | 52.51 | 46.83 | 45.20 | 40.09 | 35.41 | 30.71 | 26.03 | 22.82 | 20.24 | 17.45 | 14.16 | 13.61 | 10.89 | 10.85 | 9.61 | 7.88 | 6.95 | 6.46 | 5.92 | 5.68 | 3.97 | 3.69 |
| Total Shareholders' Equity | 7.51B | 7.28B | 6.67B | 6.15B | 5.92B | 6.09B | 6.32B | 5.5B | 5.39B | 4.99B | 4.53B | 4.25B | 3.74B | 3.25B | 2.71B | 2.3B | 1.98B | 1.75B | 1.54B | 1.52B | 1.4B | 1.21B | 1.22B | 1.09B | 917.46M | 807.9M | 716.57M | 641.6M | 627M | 526.6M | 453M |
| Common Stock | 590K | 611K | 650K | 672K | 710K | 771K | 851K | 867K | 914K | 942K | 966K | 983K | 987K | 983K | 976K | 966K | 971K | 970K | 494K | 525K | 538K | 539K | 577K | 580K | 589K | 598K | 299K | 300K | 0 | 0 | 0 |
| Retained Earnings | 8.26B | 7.99B | 7.37B | 6.8B | 5.93B | 6.06B | 6.27B | 5.47B | 5.38B | 4.98B | 4.89B | 4.57B | 4.02B | 3.5B | 2.96B | 2.49B | 2.13B | 1.88B | 1.67B | 1.6B | 1.48B | 1.26B | 1.22B | 1.05B | 851.42M | 676.06M | 576.32M | 483M | 405.2M | 325.6M | 258.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 38.26M | -717.57M | -706.5M | -650.6M | -9.67M | 30.29M | 48.12M | 31.89M | 4.24M | 7.18M | -359.02M | -317.86M | -280.43M | -250.34M | -250.06M | -198.69M | -148.19M | -129.88M | -123.62M | -82.65M | -82.06M | -51.88M | -21.41M | -2.83M | -18.69M | -6.16M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 141.43M | 133.62M | 96.61M | 52.91M | 49.46M | 108.51M | 89.39M | 79.1M | 80.82M | 68.62M | 73.69M | 302.02M | 294.69M | 268.36M | 286.91M | 269.03M | 256.76M | 238.47M | 226.74M | 0 | 174.06M | 159.88M | 186.54M | 159.55M | 140.25M | 125.91M | 120.79M | 115.6M | 129.4M | 0 | 0 |
Quick answers to the most common questions about buying UHS stock.
As of 2025, Universal Health Services, Inc. (UHS) had total assets of $15.96B including $3.41B in current assets.
Universal Health Services, Inc. (UHS) carries total debt of $5.51B, offset by $137.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Universal Health Services, Inc. (UHS) has total shareholders' equity (book value) of $7.28B ($114.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Universal Health Services, Inc. (UHS) reported a current ratio of 1.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Labor cost inflation and Medicaid cuts
Metrics are mathematically derived from official filings.
Balance Sheet Expansion with Stable Leverage
Total assets grew from $14.0B in 2024Q1 to $15.9B in 2026Q2, a 13.6% increase, while equity rose to $7.5B, per reported figures, indicating steady balance sheet strengthening.
The growth in total assets is primarily driven by increases in property, plant, and equipment (PPE), which expanded from $6.6B to $7.5B over the period, reflecting continued capital investment in facilities. Equity accumulation is supported by retained earnings, which grew from $6.9B to $8.3B, suggesting that the company is reinvesting profits to fund expansion. The balance sheet appears to be strengthening, with total liabilities growing at a slower pace than assets, implying improved financial flexibility.
Moderate Leverage with Stable Debt Levels
Total debt remained relatively stable around $5.0-5.5B over the past ten quarters, with D/E fluctuating between 0.67 and 0.84, as per balance sheet data, indicating a conservative leverage profile.
The debt-to-equity ratio has shown a slight downward trend from 0.84 in 2024Q1 to 0.69 in 2026Q2, suggesting that the company is gradually deleveraging relative to its equity base. This stability in debt levels, combined with consistent cash generation, implies that the company is not under pressure to take on additional leverage for operational needs. The moderate leverage appears strategic, supporting growth initiatives without overextending the balance sheet, and refinancing risk appears manageable given the stable debt levels.
Asset-Heavy Model with Growing PPE
Net PPE increased from $6.6B in 2024Q1 to $7.5B in 2026Q2, representing 47% of total assets, per balance sheet data, underscoring the capital-intensive nature of UHS's operations.
The significant investment in PPE reflects the company's ongoing expansion of hospital and behavioral health facilities, which is consistent with its asset-heavy business model. Goodwill remained stable at approximately $4.0B, indicating no major acquisitions or impairments during the period, but this also means that a substantial portion of assets is intangible, which could be subject to impairment risk if cash flows underperform. The growing PPE base suggests management's commitment to maintaining and expanding its physical infrastructure, which is critical for long-term competitiveness.
Retained Earnings Drive Equity Growth
Equity increased from $6.3B in 2024Q1 to $7.5B in 2026Q2, with retained earnings rising from $6.9B to $8.3B, per balance sheet data, indicating strong internal capital generation.
The growth in equity is primarily attributable to retained earnings, which have consistently increased each quarter, reflecting the company's profitability and reinvestment strategy. While the company has engaged in share repurchases, as noted in the cash flow analysis, the impact on equity appears to be offset by retained earnings growth, suggesting that buybacks are not diluting the equity base. The quality of equity is high, as it is built on accumulated profits rather than financial engineering, which supports the company's financial stability.
Adequate Liquidity with Modest Cash Buffer
Current ratio improved to 1.12 in 2026Q2 from 1.38 in 2024Q1, while cash remained around $138.8M, per balance sheet data, indicating sufficient short-term coverage but a thin cash buffer.
The current ratio has declined from 1.38 to 1.12 over the period, suggesting that current liabilities have grown faster than current assets, which may indicate tighter liquidity management. Cash levels have remained relatively flat, hovering around $120-140M, which is modest relative to the company's size and operating costs. This suggests that UHS relies on operating cash flow rather than large cash reserves to meet short-term obligations, and the liquidity position appears adequate but not overly conservative, warranting monitoring if cash flows were to deteriorate.
PPE Jump Masks Potential Data Anomaly
Net PPE spiked to $14.0B in 2026Q1 from $7.4B in 2025Q4, per balance sheet data, a near-doubling that appears inconsistent with the historical trend and may indicate a data reporting issue.
The reported PPE figure for 2026Q1 is an outlier, as it is roughly double the values seen in adjacent quarters, which could distort asset-based metrics and mislead analysts. This anomaly warrants further investigation, as it may be a data entry error or a one-time reclassification, but it should not be interpreted as a real operational change without confirmation. Investors should rely on the longer-term trend of gradual PPE growth, which is more consistent with the company's capital expenditure patterns, and treat the 2026Q1 figure with caution.